Details:

Alternative Title:
PLoS Negl Trop Dis
Publisher's site:
http://dx.doi.org/10.1371/journal.pntd.0003061
Personal Author:
Garamszegi, Sara ; Yen, Judy Y. ; Honko, Anna N. ; Geisbert, Joan B. ; Rubins, Kathleen H. ; ... More +
Garamszegi, Sara ; Yen, Judy Y. ; Honko, Anna N. ; Geisbert, Joan B. ; Rubins, Kathleen H. ; Geisbert, Thomas W. ; Xia, Yu ; Hensley, Lisa E. ; Connor, John H. ; Less -
Description:
Ebola virus (EBOV) infection in humans and non-human primates (NHPs) is highly lethal, and there is limited understanding of the mechanisms associated with pathogenesis and survival. Here, we describe a transcriptomic analysis of NHPs that survived lethal EBOV infection, compared to NHPs that did not survive. It has been previously demonstrated that anticoagulant therapeutics increase the survival rate in EBOV-infected NHPs, and that the characteristic transcriptional profile of immune response changes in anticoagulant-treated NHPs. In order to identify transcriptional signatures that correlate with survival following EBOV infection, we compared the mRNA expression profile in peripheral blood mononuclear cells from EBOV-infected NHPs that received anticoagulant treatment, to those that did not receive treatment. We identified a small set of 20 genes that are highly confident predictors and can accurately distinguish between surviving and non-surviving animals. In addition, we identified a larger predictive signature of 238 genes that correlated with disease outcome and treatment; this latter signature was associated with a variety of host responses, such as the inflammatory response, T cell death, and inhibition of viral replication. Notably, among survival-associated genes were subsets of genes that are transcriptionally regulated by (1) CCAAT/enhancer-binding protein alpha, (2) tumor protein 53, and (3) megakaryoblastic leukemia 1 and myocardin-like protein 2. These pathways merit further investigation as potential transcriptional signatures of host immune response to EBOV infection.
Subject:
[+]
Animals
Anticoagulants
Disease Models, Animal
Ebolavirus
Gene Expression Profiling
Hemorrhagic Fever, Ebola
Host-Pathogen Interactions
Leukocytes, Mononuclear
Macaca Mulatta
Microarray Analysis
Treatment Outcome

Source:
PLoS Negl Trop Dis. 2014 ; 8(7).;
Document Type:
Journal Article ;
Collection(s):
CDC Public Access
Main Document Checksum:
[+]
urn:sha256:c8548e66c8bd267622ff55cfaa48ba46c736fa8127cf4bcc9bdb9178164e7d5c
File Type:

Supporting Files

• 	pntd.0003061.e008.jpg	jpeg
  	pntd.0003061.e009.jpg	jpeg
  	pntd.0003061.e010.jpg	jpeg
  	pntd.0003061.e011.jpg	jpeg
  	pntd.0003061.e012.jpg	jpeg
  	pntd.0003061.g001.gif	gif
  	pntd.0003061.g001.jpg	jpeg
  	pntd.0003061.g002.gif	gif
  	pntd.0003061.g002.jpg	jpeg
  	pntd.0003061.g003.gif	gif
  	license.txt	txt
  	pntd.0003061.g003.jpg	jpeg
  	pntd.0003061.g004.gif	gif
  	pntd.0003061.g004.jpg	jpeg
  	pntd.0003061.g005.gif	gif
  	pntd.0003061.g005.jpg	jpeg
  	pntd.0003061.g006.gif	gif
  	pntd.0003061.g006.jpg	jpeg
  	pntd.0003061.nxml	txt
  	pntd.0003061.s001.png	png
  	pntd.0003061.s002.xls	xls
  	pntd.0003061.e001.jpg	jpeg
  	pntd.0003061.s003.xls	xls
  	pntd.0003061.t001.gif	gif
  	pntd.0003061.t001.jpg	jpeg
  	pntd.0003061.t002.gif	gif
  	pntd.0003061.t002.jpg	jpeg
  	pntd.0003061.e002.jpg	jpeg
  	pntd.0003061.e003.jpg	jpeg
  	pntd.0003061.e004.jpg	jpeg
  	pntd.0003061.e005.jpg	jpeg
  	pntd.0003061.e006.jpg	jpeg
  	pntd.0003061.e007.jpg	jpeg

More +